Maryland State Retirement & Pension System boosted its stake in shares of Synopsys, Inc. (NASDAQ:SNPS – Free Report) by 12.4% during the 3rd quarter, Holdings Channel reports. The firm owned 11,276 shares of the semiconductor company’s stock after acquiring an additional 1,246 shares during the quarter. Maryland State Retirement & Pension System’s holdings in Synopsys were worth $4,904,000 as of its most recent filing with the Securities and Exchange Commission.
Other hedge funds have also bought and sold shares of the company. Elevation Wealth Partners LLC raised its holdings in shares of Synopsys by 96.4% in the second quarter. Elevation Wealth Partners LLC now owns 55 shares of the semiconductor company’s stock worth $25,000 after buying an additional 27 shares during the last quarter. Osbon Capital Management LLC purchased a new stake in shares of Synopsys during the second quarter valued at $25,000. IMG Wealth Management Inc. purchased a new stake in shares of Synopsys during the second quarter valued at $28,000. GK Wealth Management LLC purchased a new stake in shares of Synopsys during the third quarter valued at $28,000. Finally, EFG International AG acquired a new position in shares of Synopsys in the 2nd quarter valued at $34,000. Institutional investors and hedge funds own 85.47% of the company’s stock.
More Synopsys News
Investors following SNPS have been watching these news items:
- Positive Sentiment: Synopsys is positioning its electronic design automation (EDA) tools for continued demand by adding AI-powered chip design and verification capabilities and integrating Ansys. This could support growth as chip complexity and AI investment rise. Can AI-Driven EDA Accelerate Synopsys’ Next Growth Phase?
- Positive Sentiment: Commentary highlights Synopsys’ recent run of earnings beats and its strategic role in the AI chip ecosystem, where chip designers rely on EDA software. That backdrop supports the long-term growth case, although it has not prevented recent share-price weakness. The AI Chip Race Is Getting Crowded. This Company Has Another Advantage
- Negative Sentiment: Despite estimate beats, Synopsys shares have reportedly struggled to hold post-earnings gains. Coverage identifies debt and upcoming guidance as investor concerns ahead of the December earnings report, which could keep the shares volatile. Synopsys at $460: Appealing Ahead of Dec. 8 Earnings
Insider Activity
In other news, CEO Sassine Ghazi sold 14,604 shares of the stock in a transaction dated Tuesday, September 15th. The shares were sold at an average price of $374.88, for a total transaction of $5,474,747.52. Following the sale, the chief executive officer directly owned 76,865 shares of the company’s stock, valued at $28,815,151.20. This represents a 15.97% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Aart de Geus sold 25,000 shares of the firm’s stock in a transaction dated Monday, August 31st. The shares were sold at an average price of $441.76, for a total value of $11,044,000.00. Following the sale, the insider owned 120,421 shares in the company, valued at $53,197,180.96. This trade represents a 17.19% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 117,163 shares of company stock worth $51,366,457 over the last three months. Corporate insiders own 0.56% of the company’s stock.
Analyst Upgrades and Downgrades
A number of equities analysts recently issued reports on the company. Deutsche Bank restated a “buy” rating and issued a $640.00 target price (up from $590.00) on shares of Synopsys in a research note on Thursday, October 1st. Bank of America raised their price objective on Synopsys from $500.00 to $600.00 in a research note on Thursday, October 1st. UBS Group set a $570.00 target price on Synopsys in a report on Thursday, August 27th. Robert W. Baird upgraded shares of Synopsys from a “neutral” rating to an “outperform” rating and increased their price target for the stock from $558.00 to $560.00 in a report on Thursday, August 27th. Finally, Rothschild & Co Redburn decreased their price objective on shares of Synopsys from $560.00 to $550.00 and set a “buy” rating for the company in a research note on Wednesday, September 23rd. One analyst has rated the stock with a Strong Buy rating, twenty-two have given a Buy rating and three have given a Hold rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $575.00.
View Our Latest Research Report on SNPS
Synopsys Price Performance
Shares of NASDAQ SNPS opened at $462.69 on Friday. The company has a debt-to-equity ratio of 0.29, a current ratio of 1.34 and a quick ratio of 1.24. The stock has a market capitalization of $88.67 billion, a price-to-earnings ratio of 81.75, a PEG ratio of 1.47 and a beta of 1.18. The firm’s 50 day simple moving average is $444.38 and its 200-day simple moving average is $441.35. Synopsys, Inc. has a 12 month low of $362.55 and a 12 month high of $539.48.
Synopsys (NASDAQ:SNPS – Get Free Report) last posted its earnings results on Wednesday, August 26th. The semiconductor company reported $3.91 earnings per share (EPS) for the quarter, beating the consensus estimate of $3.67 by $0.24. Synopsys had a net margin of 11.43% and a return on equity of 6.24%. The firm had revenue of $2.48 billion during the quarter, compared to analysts’ expectations of $2.44 billion. During the same period in the previous year, the business posted $3.39 EPS. The business’s revenue was up 42.4% compared to the same quarter last year. Synopsys has set its Q4 2026 guidance at 4.100-4.160 EPS and its FY 2026 guidance at 15.040-15.100 EPS. Analysts expect that Synopsys, Inc. will post 11.01 EPS for the current year.
Synopsys announced that its board has initiated a share repurchase plan on Monday, October 5th that authorizes the company to buy back $1 billion in outstanding shares. This repurchase authorization authorizes the semiconductor company to purchase up to 1.1% of its stock through open market purchases. Share repurchase plans are generally a sign that the company’s leadership believes its shares are undervalued.
Synopsys Company Profile
Synopsys, Inc. develops software, semiconductor intellectual property (IP) and services used to design and verify electronic systems. Its electronic design automation (EDA) tools help customers create, simulate, test and validate chips and other complex electronic products, while its IP portfolio provides reusable building blocks for semiconductor designs. The company also offers software security and quality tools that help developers identify vulnerabilities and assess applications throughout the software development process.
Read More
- Five stocks we like better than Synopsys
- Checkmate for AI Chips? NVIDIA’s Crisis Opens the Board
- Can NVIDIA Maintain Its Momentum Without Huang?
- Six Flags Lost $366 Million in Q3—Its Insiders Just Went Shopping
- What Went Wrong With Amprius Technologies’ Q3? Less Than You’d Think
Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS – Free Report).
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.
